Octune Pharma Solutions Private Limited

Pharmaceutical company specializing in general management, business planning, development, and regulatory affairs.

2015 | Hyderabad, Telangana (India) | Active
Last Updated: December 28, 2024

Who are the key members and board of directors at Octune Pharma Solutions?

Board Members (2)

NameDesignationAppointment DateStatus
Vayalpati Chaitanya Country flag representing In Director 29-May-2015Current
Vayalpate Dayamayi Country flag representing In Director 31-Aug-2017Current

Financial Performance of Octune Pharma Solutions.

Octune Pharma Solutions Private Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 14.06% increase. The company also saw a substantial improvement in profitability, with a 69.37% increase in profit. The company's net worth Soared by an impressive increase of 58.62%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
14.06%
Revenue from Operations
23.83%
Total Assets
-1.36%
Profit or Loss
69.37%
Net Worth
58.62%
EBITDA
536.40%

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Octune Pharma Solutions?

Unlock and access historical data on people associated with Octune Pharma Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Octune Pharma Solutions

Recent activity within the organization

  • Annual General Meeting

    Octune Pharma Solutions Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records.

    29 Sep 2018

  • Balance Sheet

    Octune Pharma Solutions Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Hyderabad.

    31 Mar 2018

  • Director Appointment

    Vayalpate Dayamayi was appointed as a Director was appointed as a Director on 31 Aug 2017 & has been associated with this company since 7 years 4 months .

    31 Aug 2017

  • Director Appointment

    Vayalpati Venkat Chaitanya was appointed as a Director was appointed as a Director on 29 May 2015 & has been associated with this company since 9 years 7 months .

    29 May 2015

  • Company Incorporation

    Octune Pharma Solutions Private Limited was registered on 29 May 2015 with Roc Hyderabad & aged 9 years 7 months as per MCA records.

    29 May 2015

Frequently asked questions

  • Octune Pharma Solutions Private Limited was incorporated on 29 May 2015.

  • The authorized share capital of Octune Pharma Solutions Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Currently 2 directors are associated with Octune Pharma Solutions Private Limited.

    • Vayalpati Venkat Chaitanya
    • Vayalpate Dayamayi
  • As per Ministry of Corporate Affairs (Mca), the registered address of Octune Pharma Solutions Private Limited is Plot No. 45 Municipal 1-98/9/45 Jai Hind Enclave, Madhapur S2 India, Hyderabad, Telangana, 500081.

  • The corporate identification number (CIN) of Octune Pharma Solutions Private Limited is U51909TG2015PTC099128 and the company number is 099128 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Octune Pharma Solutions Private Limited is https://www.octunepharma.com

  • According to the financial reports for the fiscal year 2018, the revenue trend for Octune Pharma Solutions Private Limited has risen by 14.06%.

  • The financial reports for the fiscal year 2018 indicates that The net worth of Octune Pharma Solutions Private Limited has experienced an upsurge of 58.62%.

  • The most recent Balance Sheet for Octune Pharma Solutions Private Limited was filed with the ROC on 31 Mar 2018.

People also Viewed

Similar Companies Based on Drug Formulation & Development